Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action

被引:77
作者
Wong, Chyn Boon [1 ]
Odamaki, Toshitaka [1 ]
Xiao, Jin-zhong [1 ]
机构
[1] Morinaga Milk Ind Co Ltd, Next Generat Sci Inst, 5-1-83 Higashihara, Zama, Kanagawa 2528583, Japan
关键词
Bifidobacterium longum BB536; Health benefits; Clinical efficacy; Probiotics; Gut microbiota; JAPANESE CEDAR POLLINOSIS; ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; IMMUNOSTIMULATORY DNA-SEQUENCE; HELICOBACTER-PYLORI INFECTION; RANDOMIZED DOUBLE-BLIND; FECAL MICROBIOTA; POLLEN SEASON; BILE-ACIDS; FERMENTED MILK; PROBIOTICS;
D O I
10.1016/j.jff.2019.02.002
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Probiotics have shown great promise in promoting human health. Despite the promising evidence, there is little information on the clinical efficacy of many of the available probiotics and their mechanisms of action are often unclear. Bifidobacterium longum subsp. longum BB536 is a clinically effective, well-established, multifunctional probiotic that has a long history of human use in alleviating gastrointestinal, immunological and infectious diseases. This review summarizes the functional benefits of BB536 from the most relevant clinical and animal studies and offers a theoretical basis for understanding its mechanisms of action. Key clinical findings point out that BB536 could act as a microbiome modulator to orchestrate the physiological activities of gut communities. Specifically, BB536 modulates luminal metabolism, stabilizes gut microbiota, and ultimately drives a fine-tuned homeostatic balance within the host-microbiome interaction. Clinical evidence of effectiveness of BB536 and how such multifunctional activities take place would be valuable for an optimized probiotic selection.
引用
收藏
页码:506 / 519
页数:14
相关论文
共 107 条
  • [1] Effect of production conditions on the stability of a human bifidobacterial species Bifidobacterium longum in yogurt
    Abe, F.
    Tomita, S.
    Yaeshima, T.
    Iwatsuki, K.
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 2009, 49 (06) : 715 - 720
  • [2] Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability
    Abe, Fumiaki
    Muto, Masamichi
    Yaeshima, Tomoko
    Iwatsuki, Keiji
    Aihara, Hiroaki
    Ohashi, Yuji
    Fujisawa, Tomohiko
    [J]. ANAEROBE, 2010, 16 (02) : 131 - 136
  • [3] Stability of bifidobacteria in powdered formula
    Abe, Fumiaki
    Miyauchi, Hirofumi
    Uchijima, Ayako
    Yaeshima, Tomoko
    Iwatsuki, Keiji
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, 2009, 44 (04) : 718 - 724
  • [4] Clinical Effects of Probiotic Bifidobacterium longum BB536 on Immune Function and Intestinal Microbiota in Elderly Patients Receiving Enteral Tube Feeding
    Akatsu, Hiroyasu
    Iwabuchi, Noriyuki
    Xiao, Jin-zhong
    Matsuyama, Zenjiro
    Kurihara, Rina
    Okuda, Kenji
    Yamamoto, Takayuki
    Maruyama, Mitsuo
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2013, 37 (05) : 631 - 640
  • [5] [Anonymous], HANDBOOK OF PROBIOTI
  • [6] [Anonymous], OUYOU YAKURI
  • [7] [Anonymous], 1995, BIFIDOBACTERIA MICRO
  • [8] [Anonymous], ANALGESIA RESUSCITAT
  • [9] [Anonymous], THERAPEUTICS JAPAN
  • [10] [Anonymous], FRONTIERS IN MEDICIN